|
To,
Sun Pharma Laboratories Limited
SUN House,CTS No.201/B/1,Western Express Highway, Goregaon(E)
Mumbai 400063
Subject : A retrospective cross-sectional, observational survey study to analyze role of levetiracetam as
monotherapy in partial onset seizures with newly diagnosed epilepsy
In response to your letter dated __________, I agree to participate in the study as outlined by you.
I understand that:
-
You will provide me with a copy of the data collection plan and DCFs.
-
All the data shared by me will be retrospective in nature.
-
The patient’s identity will not be disclosed in the DCF.
My personal details are given below for accuracy of your records.
|